Skip to main content
Future Journal of Pharmaceutical Sciences
Download PDF

Synthesis and anti-oxidant activity of coumarinyl chalcones

Future Journal of Pharmaceutical Sciences volume 7, Article number: 193 (2021) Cite this article

Abstract

Background

The ability to inhibit oxidative stress has been established as the prime mechanism in treatment of several disease conditions. In view of this, two new series of coumarin–chalcone hybrid molecules (5a–o and 6a–o) were synthesized using various aromatic aldehydes. The structures of the compounds were confirmed using IR, 1HNMR and mass spectral analyses. The compounds were evaluated for their antioxidant potential against 2,2-diphenyl-1-picrylhydrazyl (DPPH) and hydroxyl radicals in scavenging assays.

Results

Compounds 5o and 5k exhibited significant antioxidant potential as compared to the standard drug (ascorbic acid).

Conclusions

It can be concluded that the coumarin–chalcone treatment have the potential to be optimized further to generate scaffolds capable to treat many pathological conditions.

Background

Coumarins (2H-1-benzopyran-2-one) (I) contribute to more than 1300 secondary metabolites obtained from plants, bacteria, and fungi and therefore represent the largest class of phenolic substances found in plants [1]. The widespread availability of coumarins in nature has been instrumental for the wide spectrum biological activities exhibited by the natural coumarins. Several synthetic derivatives of coumarins have been explored for activities including antibacterial [2], antifungal [3], anticancer [4], anti-HIV [5], anti-inflammatory [6] etc. Al-Majedy et al. have reported a detailed review on the antioxidant action of synthetic coumarin derivatives [7].

Chalcones (II) are molecules containing a 1,3-diphenylprop-2-en-1-one obtained from the flavonoid class of natural products. Several chalcone compounds have been isolated from plant sources and aplenty synthetic derivatives have been produced in laboratories by substituting on the benzene rings. Most of the biological actions exhibited by chalcones as owed to their antioxidant potential [8].

Reports have been made where linking two distinct moieties together using various functional groups or spacers has resulted in synergizing the action of the resulting molecules [9,10,11,12,13,14,15,16,17]. In persuasion to the reports, we envisaged to fuse coumarin and chalcone nucleuses to form novel conjugates and evaluate the antioxidant potential of the conjugates.

Methods

General

Melting points were determined using open capillary tubes and the reported results are uncorrected. Infrared spectra (KBr) were obtained on Bruker FTIR spectrophotometer. 1H NMR spectra were recorded on Bruker AVANCE-III 400 MHz spectrometer in the suitable solvent using TMS as the internal standard and the mass spectra were obtained on Applied Biosystems 3200 Q-Trap spectrometer. Purity of the compounds was checked by TLC.

Chemistry

The synthesis of the coumarin–chalcone hybrid molecules was accomplished according the reaction depicted in Scheme 1. The steps of the present scheme were adapted with modifications form the scheme reported by Tandel et al. [18] and Srikrishna et al. [19].

Scheme 1
scheme 1

Reaction scheme for the synthesis of coumarin-chalcone conjugates

Full size image

4-chloro-2-oxo-2H-chromene-3-carbaldehyde (2)

To a cooled solution of DMF (25 mL) and POCl3 (5 mL) at 0–5 °C was added 4-hydroxycoumarin (1) (5 mmol). The reaction mixture was stirred for 2–3 h at room temperature. On completion of reaction, as monitored on TLC (chloroform-acetone 3:2), the mixture was poured into ice-cold water (30 mL). The separated solid was filtered, washed with two 15 mL portions of water and dried to obtain. The crude product was recrystallized from a methanol gave pure carbaldehyde.

4-Morpholino-2-oxo-2H-chromene-3-carbaldehyde (3)

A solution of morpholine (21.75 g, 20 mmol) in 10 ml of dichloromethane was gradually added under constant stirring to an ice-cooled mixture of 2 (2.09 g, 10 mmol) in 25 mL of dichloromethane. After stirring for 30 min at 0–5 °C, the mixture was washed with three 10 mL portions of water to remove any unreacted morpholine and its salt. The organic phase was dried over MgSO4 and the solvent was evaporated under reduced pressure. The dry residual flakes were recrystallized from 1,4-dioxane to obtain pure 3 [20].

(E)-3-(3-(4-aminophenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one (4)

4-Morpholino-2-oxo-2H-chromene-3-carbaldehyde (3, 0.031 mmol) and 4-amino acetophenone (0.03 mmol) were dissolved in chloroform (30 mL). A catalytic amount of piperidine (0.02 mmol) was added and the reaction mixture was refluxed for 1.5 h. Chloroform was distilled out from the mixture and the residue was washed with methanol to obtain the pure chalcone (4) [21].

General method of synthesis of 3-((E)-3-(4-((Z)-benzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one (5a–o)

In a round bottom flask compound 4 (0.0329 mol) was dissolved in methanol (20 mL). Separately, substituted benzaldehyde (0.0329 mol) was dissolved in methanol (20 mL) in a beaker. The solution of substituted benzaldehyde was added drop by drop in to the solution of 4 with continuous stirring. On completion of addition, the mixture was allowed to reflux for 4 h. On completion of reaction, the reaction mixture was poured in to an evaporating dish and the excess of solvent was removed under reduced pressure. The solid obtained crystallized using methanol [22].

3-((E)-3-(4-((Z)-4-hydroxybenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5a

Color: Dark Yellow; IR (KBr, cm−1): 3420 (–OH str), 1652 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1098 (–C–O–C str, morpholine), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 4.9 (OH); Mass: 481.6 (M + 1).

3-((E)-3-(4-((Z)-2-nitrobenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5b

Color: Dark Yellow; IR (KBr, cm−1): 1658 (–C = O str, chalcone), 1719 (–C = O str, coumarin), 1098 (–C–O–C str, morpholine), 1465 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.4 (H, imine), 8.2 (H, adj. NO2); Mass: 510.3 (M + 1).

3-((E)-3-(4-((Z)-3-nitrobenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5c

Color: Pale Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1710 (–C = O str, coumarin), 1095 (–C–O–C str, morpholine), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (-O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 8.5 (H, adj. NO2); Mass: 510.6 (M + 1).

3-((E)-3-(4-((Z)-4-nitrobenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5d

Color: Dark Yellow; IR (KBr, cm−1): 1658 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1098 (–C–O–C str, morpholine), 1470 (–C = C str, aromatic); 1H NMR (DMSO, δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.4 (H, imine), 8.2 (H, adj. NO2); Mass: 510.5 (M + 1).

3-((E)-3-(4-((Z)-2-hydroxybenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5e

Color: Dark Yellow; IR (KBr, cm−1): 3422 (–OH str), 1648 (–C = O str, chalcone), 1710 (–C = O str, coumarin), 1098 (–C–O–C str, morpholine), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 4.9 (OH); Mass: 481.3 (M + 1).

3-((E)-3-(4-((Z)-3,4-dimethoxybenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5f

Color: Pale Yellow; IR (KBr, cm−1): 1652 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1098 (–C–O–C str, morpoline), 1468 (–C = C str, aromatic); 1H NMR (DMSO, δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.3 (H, imine), 3.8 (CH3, methoxy); Mass: 525.4 (M + 1).

3-((E)-3-(4-((Z)-2-chlorobenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5g

Color: Dark Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1715 (–C = O str, coumarin), 1097 (–C–O–C str, morpoline), 1463 (–C = C str, aromatic), 765 (C–Cl); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine); Mass: 500.1 (M + 1).

3-((E)-3-(4-((Z)-3-chlorobenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5h

Color: Dark Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1715 (–C = O str, coumarin), 1097 (–C–O–C str, morpoline), 1463 (–C = C str, aromatic), 755 (C–Cl); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine); Mass: 500.1 (M + 1).

3-((E)-3-(4-((Z)-benzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5i

Color: Dark Yellow; IR (KBr, cm−1): 1652 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1098 (–C–O–C str, morpoline), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine); Mass: 467.3 (M + 1).

3-((E)-3-(4-((Z)-4-methoxybenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one. 5j

Color: Yellow; IR (KBr, cm−1): 1655 (–C = O str, chalcone), 1718 (–C = O str, coumarin), 1095 (–C–O–C str, morpoline), 1466 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 3.8 (H, methoxy); Mass: 498.0 (M + 1).

3-((E)-3-(4-((Z)-4-hydroxy-3-methoxybenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5k

Color: Dark Yellow; IR (KBr, cm−1): 3600 (–OH str), 1650 (–C = O str, chalcone), 1717 (–C = O str, coumarin), 1097 (–C–O–C str, morpoline), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (-N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 5.1 (OH), 3.7 (H, methoxy); Mass: 513.8 (M + 1).

3-((E)-3-(4-((Z)-3-bromobenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5l

Color: Dark Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1710 (–C = O str, coumarin), 1094 (–C–O–C str, morpoline), 1459 (–C = C str, aromatic), 610 (C–Br); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine); Mass: 543.3 (M + 1).

3-((E)-3-(4-((Z)-4-bromobenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5m

Color: Dark Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1710 (–C = O str, coumarin), 1094 (–C–O–C str, morpoline), 1459 (–C = C str, aromatic), 610 (C–Br); 1H NMR (DMSO, δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine); Mass: 543.3 (M + 1).

3-((E)-3-(4-((Z)-4-chlorobenzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5n

Color: Dark Yellow; IR (KBr, cm−1): 1652 (–C = O str, chalcone), 1710 (–C = O str, coumarin), 1097 (–C–O–C str, morpoline), 1463 (–C = C str, aromatic), 763 (C–Cl); 1H NMR (DMSO, δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine); Mass: 500.1 (M + 1).

3-((E)-3-(4-((Z)-4-(dimethylamino)benzylideneamino)phenyl)-3-oxoprop-1-enyl)-4-morpholino-2H-chromen-2-one, 5o

Color: Pale Yellow; IR (KBr, cm−1): 1652 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1096 (–C–O–C str, morpoline), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 2.9 (H, N–CH3); Mass: 508.6 (M + 1).

General method of synthesis of 3-((1E,3E)-3-(4-((Z)-benzylideneamino)phenyl)-3-(methylimino)prop-1-enyl)-4-morpholino-2H-chromen-2-one (6a–o)

A mixture of 5(a–o) (5 mmol), methylamine (5 mmol) and acetic acid (10 mL) was stirred at room temperature for 10 min. Then, the mixture was poured into ice-cold water (30 mL). The separated solid was filtered, washed with two 5 mL portions of aqueous acetic acid (1:1) and dried. The crude product was recrystallized from suitable 1,4-dioxane to obtain pure compounds 6a–o [19, 22].

3-((1E,3E)-3-(4-(((Z)-4-hydroxybenzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6a

Color: Dark Yellow; IR (KBr, cm−1): 3420 (–OH str), 1652 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1098 (–C–O–C str, morpholine), 1468 (–C = C str, aromatic); 1H NMR (DMSO, δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 4.9 (OH), 3.5 (N-CH3); Mass: 493.5 (M + 1).

3-((1E,3E)-3-(methylimino)-3-(4-(((Z)-2-nitrobenzylidene)amino)phenyl)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6b

Color: Dark Yellow; IR (KBr, cm−1): 1658 (–C = O str, chalcone), 1719 (–C = O str, coumarin), 1098 (–C–O–C str, morpholine), 1465 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.4 (H, imine), 8.2 (H, adj. NO2) 3.4 (N-CH3); Mass: 525.7 (M + 1).

3-((1E,3E)-3-(methylimino)-3-(4-(((Z)-3-nitrobenzylidene)amino)phenyl)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6c

Color: Pale Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1710 (–C = O str, coumarin), 1095 (–C–O–C str, morpholine), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 8.5 (H, adj. NO2), 3.5 (N-CH3), 3.5 (N-CH3); Mass: 525.6 (M + 1).

3-((1E,3E)-3-(methylimino)-3-(4-(((Z)-4-nitrobenzylidene)amino)phenyl)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6d

Color: Dark Yellow; IR (KBr, cm−1): 1658 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1098 (–C–O–C str, morpholine), 1470 (–C = C str, aromatic); 1H NMR (DMSO, δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.4 (H, imine), 8.2 (H, adj. NO2), 3.5 (N-CH3); Mass: 525.5 (M + 1).

3-((1E,3E)-3-(4-(((Z)-2-hydroxybenzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6e

Color: Dark Yellow; IR (KBr, cm−1): 3422 (–OH str), 1648 (–C = O str, chalcone), 1710 (–C = O str, coumarin), 1098 (–C–O–C str, morpholine), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 4.9 (OH), 3.5 (N-CH3); Mass: 494.4 (M + 1).

3-((1E,3E)-3-(4-(((Z)-3,4-dimethoxybenzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6f

Color: Pale Yellow; IR (KBr, cm−1): 1652 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1098 (–C–O–C str, morpoline), 1468 (–C = C str, aromatic); 1H NMR (DMSO, δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.3 (H, imine), 3.8 (CH3, methoxy), 3.4 (N-CH3); Mass: 538.8 (M + 1).

3-((1E,3E)-3-(4-(((Z)-2-chlorobenzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6g

Color: Dark Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1715 (–C = O str, coumarin), 1097 (–C–O–C str, morpoline), 1463 (–C = C str, aromatic), 765 (C–Cl); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 3.4 (N-CH3); Mass: 513.1 (M + 1).

3-((1E,3Z)-3-(4-(((Z)-3-chlorobenzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6h

Color: Dark Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1715 (–C = O str, coumarin), 1097 (–C–O–C str, morpoline), 1463 (–C = C str, aromatic), 755 (C–Cl); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 3.5 (N-CH3); Mass: 513.4 (M + 1).

3-((1E,3Z)-3-(4-(((Z)-benzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6i

Color: Dark Yellow; IR (KBr, cm−1): 1652 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1098 (–C–O–C str, morpoline), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 3.4 (N-CH3); Mass: 479.1 (M + 1).

3-((1E,3Z)-3-(4-(((Z)-4-methoxybenzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6j

Color: Yellow; IR (KBr, cm−1): 1655 (–C = O str, chalcone), 1718 (–C = O str, coumarin), 1095 (–C–O–C str, morpoline), 1466 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 3.8 (H, methoxy), 3.4 (N-CH3); Mass: 508.3 (M + 1).

3-((E)-3-(4-(((Z)-4-hydroxy-3-methoxybenzylidene)amino)phenyl)-3-oxoprop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6k

Color: Dark Yellow; IR (KBr, cm−1): 3600 (–OH str), 1650 (–C = O str, chalcone), 1717 (–C = O str, coumarin), 1097 (–C–O–C str, morpoline), 1468 (–C = C str, aromatic); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 5.1 (OH), 3.7 (H, methoxy), 3.4 (N-CH3); Mass: 511.4 (M + 1).

3-((1E,3Z)-3-(4-(((Z)-3-bromobenzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6l

Color: Dark Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1710 (–C = O str, coumarin), 1094 (–C–O–C str, morpoline), 1459 (–C = C str, aromatic), 610 (C–Br); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 3.4 (N-CH3); Mass: 557.3 (M + 1).

3-((1E,3Z)-3-(4-(((Z)-4-bromobenzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6m

Color: Dark Yellow; IR (KBr, cm−1): 1650 (–C = O str, chalcone), 1710 (–C = O str, coumarin), 1094 (–C–O–C str, morpoline), 1459 (–C = C str, aromatic), 610 (C–Br); 1H NMR (DMSO,δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 3.5 (N-CH3); Mass: 557.6 (M + 1).

3-((1E,3Z)-3-(4-(((Z)-4-chlorobenzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6n

Color: Dark Yellow; IR (KBr, cm−1): 1652 (-C = O str, chalcone), 1710 (-C = O str, coumarin), 1097 (-C–O–C str, morpoline), 1463 (-C = C str, aromatic), 763 (C–Cl); 1H NMR (DMSO,δ): 3.1–3.5 (-N(CH2)2), 3.7–3.9 (-O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 3.5 (N-CH3); Mass: 523.2 (M + 1).

3-((1E,3Z)-3-(4-(((Z)-4-(dimethylamino)benzylidene)amino)phenyl)-3-(methylimino)prop-1-en-1-yl)-4-morpholino-2H-chromen-2-one, 6o

Color: Pale Yellow; IR (KBr, cm−1): 1652 (–C = O str, chalcone), 1712 (–C = O str, coumarin), 1096 (–C–O–C str, morpoline), 1468 (–C = C str, aromatic); 1H NMR (DMSO, δ): 3.1–3.5 (–N(CH2)2), 3.7–3.9 (–O(CH2)2), 6.7–7.8 (H, Ar), 8.2 (H, imine), 2.9 (H, N-CH3), 3.5 (N-CH3); Mass: 521.6 (M + 1).

In-vitro antioxidant activity

The in vitro antioxidant activity of the synthesized compounds 5a–o and 6a–o was determined by two different methods using ascorbic acid as the standard.

DPPH method

The free radical scavenging activity of the synthesized molecules was measured in terms of hydrogen donating or radical scavenging ability using the stable radical DPPH [23]. The test samples (10–100 μL) were prepared in DMSO and were mixed with 1.0 mL of DPPH solution and filled up with methanol to a final volume of 4 mL. Absorbance of the resulting solution was measured at 517 nm in a visible spectrophotometer. Ascorbic acid was used as the reference compound. Lower absorbance of the reaction mixture indicated higher free radical scavenging activity. Radical scavenging activity was expressed as the inhibition percentage of free radical by the sample and was calculated using the following formula:

$$\% inhibition = \frac{{\left( {Ao - At} \right)}}{Ao} \times 100$$

where Ao is the absorbance of the control (blank, without sample) and At is the absorbance in the presence of the test samples. All tests were performed in triplicate and the results were expressed as mean values ± standard deviations.

Hydroxyl radical scavenging method

The test samples (10–100 μL) were prepared in DMSO and 1 mL of iron EDTA solution, 0.5 mL of EDTA solution, 1 mL of DMSO and 0.5 mL of ascorbic acid were added to it. The mixture was incubated in a boiling water bath at 80 to 90 °C for 15 min. After incubation, 1 mL of ice cold TCA and 3 mL of Nash reagent were added and the reaction mixture was incubated at room temperature for 15 min. The absorbance was read at 412 nm. The % hydroxyl radical scavenging activity is calculated by the following formula

$${\% }HRSA = \frac{Abs\;control - Abs\;sample}{{Abs\;control}} \times 100$$

where, HRSA is the Hydroxyl Radical Scavenging Activity, Abs control is the absorbance of control and Abs sample is the absorbance of the test solution.

Results

Chemistry

Table 1 presents the physical data and chemical structures of all the synthesized compounds.

Table 1 Physical characterization data and chemical structure of 5a–o & 6a–o
Full size table

Antioxidant action

The antioxidant activity displayed by the synthesized compounds against DPPH and hydroxyl radicals is presented in Tables 2 and 3.

Table 2 IC50 values of 5a–o
Full size table
Table 3 IC50 values of 6a-o
Full size table

Discussion

Chemistry

Two series of newer coumarin-chalcone conjugates 5a-o and 6a-o were synthesized utilizing Scheme 1. Carbaldehyde 2 resulted by the reaction of 4-hydroxy coumarin 1 with Vilsmeier-Haack reagent leading to formylation of the electron rich ring [24]. Compound 2 undergoes nucleophilic aromatic substitution with morpholine to yield the compound 3 which on condensation with amino acetophenone under the conditions of Claisen-Schmidt reaction yielded the chalcone conjugates 4. The coumarin-chalcone conjugates were further condensed at reflux conditions with aromatic aldehydes and methyl amine to obtain compounds 5a–o and 6a–o. The optimization of the reaction for completion and purity was performed throughout using TLC. The structures of the synthesized molecules were characterized by 1H NMR, IR and mass spectral studies.

The 1H NMR spectra of compound 5a–o exhibited peaks in the region of 3.1–3.9 corresponding to -N(CH2)2 and -O(CH2)2; 6.7–7.8 due to aromatic protons, the peaks due to α, β-unsaturation of chalcones; 8.2 owing to the imine protons. Additionally, the signals due to the hydroxyl and methoxy protons were also found in the corresponding compounds. In the 1H NMR spectra of compound 6a–o additional peak at 3.3–3.5 was obtained due the methyl protons of methylamine. The mass spectra of all the compounds displayed M + 1 peaks corresponding to their molecular formula.

Antioxidant action

As known, free radical scavenging is one of most perceived mechanisms for any antioxidant to inhibit oxidation of lipids. The standard assay protocols to evaluate the free radical scavenging activity include the DPPH and the hydroxyl radical scavenging activity assays. The antioxidant potential of the compounds 5a–o and 6a–o was assessed using these two methods using ascorbic acid as the standard.

DPPH radicals are stable free radicals whose radical character is neutralized in the presence of molecules that may donate H atoms. The reduction of the DPPH radical can be spectrophotometrically determined by the decreased absorbance at 517 nm caused due to antioxidants.

Hydroxyl radical scavenging assay is used to find the antioxidant activity of test compounds against free hydroxyl radicals like hydrogen peroxide (known cause damage to the cells). The model used is ascorbic acid-iron-EDTA model of hydroxyl radical generating system. This is a totally aqueous system wherein ascorbic acid, iron and EDTA combine with each other to generate hydroxyl radicals.

As it can be seen from results tabulated in Table 3, compounds 5a, 5e, 5f, 5k and 5o had DPPH and hydroxyl radical scavenging activity comparable to the standard drug ascorbic acid while the remaining compounds exhibited very high IC50 values. It was also observed that the IC50 values of the compounds were lower for hydroxyl radical scavenging (14.4 to 33.8 µg/mL) as compared to DPPH radical scavenging (15.3 to 37.4 µg/mL). Compounds 5o and 5 k were found to be exhibiting better inhibition of the hydroxyl radical with IC50 values 14.4 and 15.5 respectively as compared to ascorbic acid (15.7).

The results highlighted the importance of the carbonyl group of the chalcone molecule in the antioxidant action as the IC50 values of compounds 6a–o was comparatively poor to that of 5a–o. The absence of the carbonyl carbon could be attributed to the decreased antioxidant action of 6a-o. A similar decrease in antioxidant potential was reported by Lahsasni et al. [25] where they condensed the carbonyl carbon and the double bond into pyridine ring to obtain compounds which were less potential antioxidants when compared to the corresponding α, β- unsaturated carbonyl compounds. The excellent antioxidant capacity of 5a, 5e, 5f, 5k and 5o reaffirmed the concept that organic molecules containing electron donating groups have better capacity to neutralize free radicals and oppose oxidation [26].

Conclusions

Two series of coumarin-chalcone hybrid molecules were synthesized in good yields using Vilsmeier-Haack, nucleophilic aromatic substitution and Claisen-Schmidt condensation reaction and characterized by spectral studies. The synthesized compounds exhibited good antioxidant potential against DPPH and hydroxyl radicals in the scavenging assays with compounds 5o and 5k being the most significant against the tested radicals.

Availability of data and materials

Not applicable.

Abbreviations

FTIR:

Fourier-Transform Infrared Spectroscopy

DMF:

Dimethylformamide

TLC:

Thin layer chromatography

NMR:

Nuclear Magnetic Resonance

HRSA:

Hydroxyl Radical Scavenging Activity

DPPH:

2,2-Diphenyl-1-picrylhydrazyl

DMSO:

Dimethyl sulfoxide

EDTA:

Ethylene Diamine Tetra Acetic Acid

References

  1. Aoyama Y, Katayama T, Yamamoto M, Tanaka H, Kon K (1992) A new antitumor antibiotic product, demethylchartreusin. Isol Biol Activities J Antibiot 45(6):875–878

    Article  CAS  Google Scholar 

  2. Al-Amiery AA, Al-Majedy YK, Al-Duhaidahawi D, Kadhum AAH, Mohamad AB (2016) Green antioxidants: synthesis and scavenging activity of coumarin-thiadiazoles as potential antioxidants complemented by molecular modeling studies. Free Radic Antioxidants 6(2):173–177

    Article  CAS  Google Scholar 

  3. Al-Amiery AA, Kadhum AAH, Mohamad AA (2012) Antifungal activities of new coumarins. Molecules 17(5):5713–5723

    Article  CAS  Google Scholar 

  4. Al-Azawi F, Al-Baghdadi S, Mohamed A, Al-Amiery A, Abed T, Mohammed S, Kadhum AAH, Mohamad AB (2016) Synthesis, inhibition effects and quantum chemical studies of a novel coumarin derivative on the corrosion of mild steel in. Chem Cent J 10(1):1–9

    Article  Google Scholar 

  5. Al-Ayed AS (2011) Synthesis, spectroscopy and electrochemistry of new 3-(5-Ar-yl-4,5-Dihydro-1H-Pyrazol-3-yl)-4-hydroxy-2H-chromene-2-one 4, 5 as a novel class of potential anti- bacterial and antioxidant derivatives. Int J Org Chem 1(03):87–96

    Article  CAS  Google Scholar 

  6. Al-Amiery AA, Kadhum AAH, Mohamad AB, Musa AY, Li CJ (2013) Electrochemical study on newly synthesized chlorocurcumin as an inhibitor for mild steel corrosion in hydrochloric acid. Materials 6(12):5466–5477

    Article  CAS  Google Scholar 

  7. Al-Majedy Y, Al-Amiery A, Khadum AA, Mohamad AB (2017) Antioxidant activity of coumarins. Syst Rev Pharm 8(1):24–30

    Article  CAS  Google Scholar 

  8. Stepanic V, Matijasic M, Horvat T, Verbanac D, Kucerová-Chlupácová M, Saso L, Žarkovic N (2019) Antioxidant activities of alkyl substituted pyrazine derivatives of chalcones—in vitro and in silico study. Antioxidants 8:90–101

    Article  CAS  Google Scholar 

  9. Mishra R, Jain S (2013) In vitro anti-malarial evaluation of some thiazole containing chalcone derivatives. PharmacologyOnLine 2:106–109

    Google Scholar 

  10. Mishra R, Jain S (2013) Investigation of antimicrobial potential of some thiazolyl chalcone derivatives. PharmacologyOnline 1:190–193

    Google Scholar 

  11. Milan C, Maja M, Tomislav B, Nela D, Valentina R (2009) Design and synthesis of some thiazolidin-4-ones based on(7-hydroxy-2-oxo-2h-chromen-4-yl) acetic acid. Molecules 14(7):2501–2513

    Article  Google Scholar 

  12. Jayashree BS, Kumar A, Pai A (2011) Synthesis characterization and antidiabetic evaluation novel coumarin analogues. Pharmacol Online 3:1061–1076

    Google Scholar 

  13. Garazd MM, Muzychka OV, Voyk AI, Nagorichna IV. Ogorodniichuk AS (2007) Modified coumarins. 27. Synthesis and antioxidant activity of 3-substituted 5,7-dihydroxy-4-methyl coumarins. Chem Nat Compd 43(1):19–23.

  14. Hamdi N, Puerta MC, Valerga P (2008) Synthesis, structure, antimicrobial and antioxidant investigations of dicoumarol and related compounds. Eur J Med Chem 43(11):2541–2548

    Article  CAS  Google Scholar 

  15. Tripathi N, Patel P, Mishra R, Mishra B, Balasubramaniam A (2013) Chemical and pharmacological evaluation of Pyrimidine derivatives of Thiazolidinedion. Asian J Pharm Educ Res 2(2):43–57

    Google Scholar 

  16. Mishra BJ (2017) Synthesis of 1,8-Napthyridine derivatives and their evaluation as possible antiepileptic agents. J Pharmacol Biomed 1(1):1–8

    Google Scholar 

  17. d’Oliveira GDC, Moura AF, de Moraes MO, Perez CN, Lião LM (2018) Synthesis, characterization and evaluation of in vitro antitumor activities of novel chalcone-quinolinone hybrid compounds. J Braz Chem Soc 29(11):2308–2325

    Google Scholar 

  18. Tandel H, Chikalia KH, Patel SK (2019) Synthesis and antibacterial activity of novel coumarin-chalcone hybrids. Indian J Chem 58B:594–602

    CAS  Google Scholar 

  19. Srikrishna D, Dubey PK (2017) Facile, stepwise and diversity oriented synthesis of 3-(2-Oxo-2H-Chromen-3-yl)-1-Phenyl-1H-Pyrazole-4-carbaldehydes. J Chem Pharm Res 9(11):99–108

    CAS  Google Scholar 

  20. Iliev BI, Ivanov IC (2001) 4-Morpholino-2-oxo-2H-chromene-3-carbaldehyde. Molecules 6:M218

    Article  CAS  Google Scholar 

  21. Al-Ayed AA (2011) Synthesis of new substituted chromen[4,3-c]pyrazol-4-ones and their antioxidant activities. Molecules 16:10292–10302

    Article  CAS  Google Scholar 

  22. Avalakki AS, Jadhav SB, Bandawane DD, Bhalekar PA (2019) Synthesis and antidiabetic evaluation of some novel compounds. Indian J Chem 58B:849–854

    CAS  Google Scholar 

  23. Blois MS (1958) Antioxidant determinations by the use of a stable free radical. Nature 181(4617):1199–1200

    Article  CAS  Google Scholar 

  24. Dongamati A, Bachi Reddy V, Mdderla S, Vijaya Lakshmi B (2017) Microwave assisted synthesis of substituted 4-chloro-8-methyl-2–(1,3-diphenyl-1H-pyrazol-4-yl)-1,5-dioxa-2H-phenanthren-6–ones and their antimicrobial activity. J Serbian Chem Soc 82(2):117–125

    Article  Google Scholar 

  25. Lahsasni SA, Al Korbi FH, Aljaber NAZ (2014) Synthesis, characterization and evaluation of antioxidant activities of some novel chalcones analogues. Chem Central J 8: 32; doi: https://doi.org/10.1186/1752-153X-8-32.

  26. Mohana KN, Pradeep Kumar CB (2013) Synthesis and antioxidant activity of 2-amino-5-methylthiazol derivatives containing 1,3,4-oxadiazole-2-thiol moiety. ISRN Org Chem. https://doi.org/10.1155/2013/620718

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Pharmacy, Oriental University, Madhya Pradesh, Indore, 453555, India

    Raj Keshwar Prasad & Kavita R. Loksh

Authors
  1. Raj Keshwar Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kavita R. Loksh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RKP performed all the synthetic and biological activity work. KRL was involved in interpreting the results and preparing the manuscript. All authors read and approved the manuscript.

Corresponding author

Correspondence to Raj Keshwar Prasad.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prasad, R.K., Loksh, K.R. Synthesis and anti-oxidant activity of coumarinyl chalcones. Futur J Pharm Sci 7, 193 (2021). https://doi.org/10.1186/s43094-021-00340-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43094-021-00340-1

Keywords